Yahoo India Web Search

Search results

1. People also ask

   What is a new treatment for COPD?

   • These newer treatments are medications called biologic drugs. For example, some people with COPD have a large number of eosinophils, a specific type of white blood cell. A drug called anti-interleukin-5 (IL-5) targets airway inflammation caused by eosinophils. This drug lowers the number of blood eosinophils, helping to reduce COPD symptoms.

   New Treatments for COPD: Inhalers, Surgery, and More - Healthline

   www.healthline.com/health/copd/new-treatments-copd

   See all results for this question

   What's new in COPD care & management?

   • And it's just one of several recent advances in COPD care and management. From innovative new lung valves to refinements in the deployment of inhaled therapies and vaccines, the landscape of COPD care and treatment is changing.

   New Advances in Managing COPD | TIME

   time.com/6903546/copd-treatment-advances/

   See all results for this question

   Is there a triple inhaled treatment for COPD?

   • The first approved triple inhaled therapy for COPD was called fluticasone / umeclidinium / vilanterol (Trelegy Ellipta). In 2020, the FDA approved a second: budesonide/glycopyrrolate/formoterol fumarate (Breztri Aerosphere). COPD can cause low oxygen levels. This can make you feel dizzy, confused, and fatigued.

   New Treatments for COPD: Inhalers, Surgery, and More - Healthline

   www.healthline.com/health/copd/new-treatments-copd

   See all results for this question

2. www.healthline.com › health › copdNew Treatments for COPD: Inhalers, Surgery, and More - Healthline

   www.healthline.com › health › copd

   • Cached

   Apr 5, 2024 · Learn about existing and new treatment options for COPD, such as inhalers, oxygen therapy, surgery, and biologic medication. Find out how to manage your symptoms and improve your quality of life with COPD.

   • Author: Valencia Higuera

3. time.com › 6903546New Advances in Managing COPD | TIME

   time.com › 6903546

   • Cached

   Mar 18, 2024 · From innovative new lung valves to refinements in the deployment of inhaled therapies and vaccines, the landscape of COPD care and treatment is changing.

4. www.mayoclinic.org › medical-professionalsNew frontiers in the treatment of COPD - Mayo Clinic

   www.mayoclinic.org › medical-professionals

   • Cached

   Dec 3, 2021 · Treatment for patients with chronic obstructive pulmonary disease (COPD) — including emphysema, chronic bronchitis and COPD exacerbation — can be tailored to each patient's phenotype.

5. Videos

   • 

     56:00

     youtube.com

     Critical Advancements: Minimally Invasive Treatment for Severe COPD

     6 Dec 2022

     18.7K views

   • 

     2:23

     cbsnews.com

     New treatment for people with COPD, emphysema at Penn Medicine

     6 Jan 2023

   • 

     7:13

     youtube.com

     COPD: New, Simplified Treatment Guidelines

     1 Feb 2023

     35.4K views

   View all

6. www.patientcareonline.com › view › fda-approval-ofFDA Approval of Dupilumab for Uncontrolled COPD will Change ...

   www.patientcareonline.com › view › fda-approval-of

   • Cached

   2 days ago · Dupilumab represents the first new treatment approach for uncontrolled COPD in more than a decade and reduced disease exacerbations by 34% in clinical trials. Respiratory Tripledemic 2022-23: An Expert Recap

7. www.thelancet.com › journals › lanresGOLD COPD report: 2023 update - The Lancet Respiratory Medicine

   www.thelancet.com › journals › lanres

   Nov 30, 2022 · On Nov 14, 2022, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) published their 2023 global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (COPD). Highlights from the 2023 report were presented at the 2022 GOLD International COPD conference.

8. www.ajmc.com › view › fda-approves-ensifentrine-forFDA Approves Ensifentrine for Maintenance Treatment of Adult ...

   www.ajmc.com › view › fda-approves-ensifentrine-for

   • Cached

   Jun 26, 2024 · Today, the FDA approved ensifentrine (Ohtuvayre; Verona Pharma) for the maintenance treatment of moderate to severe chronic obstructive pulmonary disease (COPD) based on the successful phase 3...

9. www.nejm.org › doi › fullDupilumab for COPD with Type 2 Inflammation Indicated by ...

   www.nejm.org › doi › full

   May 21, 2023 · In symptomatic patients with COPD and evidence of type 2 inflammation who had a high risk of COPD exacerbation despite the use of standard triple therapy, treatment with dupilumab resulted...